The integration of artificial intelligence in healthcare has evolved through three distinct phases: initial caution, a period of technological hype, and a current shift toward critical evaluation. Medical organizations are moving away from the impulsive adoption of AI tools toward a focus on measurable clinical and operational benefits.
A notable example of successful implementation is the ArtInCol system, developed by the A.N. Ryzhikh National Medical Research Center for Coloproctology. This AI-driven tool analyzes endoscopy video streams in real time to assist in detecting polyps and early-stage neoplasms, demonstrating a clear clinical application.
Despite individual successes, healthcare managers face challenges with the fragmented nature of AI solutions. Current offerings, such as voice-to-text documentation, HR assistants, and patient communication tools, often function as isolated systems that require separate integration, training, and maintenance costs.
The primary concern for medical administrators remains the lack of clear economic models for AI adoption. There is currently insufficient data on the total cost of ownership, potential return on investment, and the long-term impact on physician workload, burnout, and the overall quality of patient care.
The industry is increasingly prioritizing the concept of 'trusted AI,' which emphasizes system control, result verification, and risk management. Experts highlight that technology alone does not solve medical or management problems without a deep restructuring of existing organizational processes.
